Tag: CAPA

Template: OOS Investigation Report for QC Laboratories

November 25, 2025November 25, 2025 digi

Template: OOS Investigation Report for QC Laboratories Step-by-Step Guide to OOS Investigations in QC Laboratory: Report Template and CAPA Implementation Out-of-specification (OOS) results in Quality Control (QC) laboratory testing represent a critical challenge within pharmaceutical manufacturing. Regulatory agencies such as the FDA, EMA, and MHRA require systematic and thorough investigations to determine the root cause…

OOS Investigations

Case Studies: Assay and Content Uniformity Failures in QC

November 25, 2025November 25, 2025 digi

Case Studies: Assay and Content Uniformity Failures in QC Case Studies in Assay and Content Uniformity Testing: Understanding and Correcting Failures Assay and content uniformity testing remain critical quality control operations in pharmaceutical manufacturing. These tests ensure that drug products meet specified potency and dosage uniformity requirements, as mandated by global regulatory frameworks such as…

Assay & CU

Case Studies: Failures in Uniformity of Dosage Units and CAPA

November 24, 2025November 24, 2025 digi

Case Studies: Failures in Uniformity of Dosage Units and CAPA Case Studies: Failures in Uniformity of Dosage Units and Corrective Actions The uniformity of dosage units is a critical quality attribute in pharmaceutical manufacturing. Regulatory agencies such as the FDA, EMA, and MHRA mandate strict adherence to testing and control to ensure patient safety and…

Uniformity of dosage units in process controls

Yield Reconciliation Deviations: Investigation Approach and CAPA Examples

November 24, 2025November 24, 2025 digi

Yield Reconciliation Deviations: Investigation Approach and CAPA Examples Comprehensive Step-by-Step Guide to Yield Reconciliation Deviations Investigation Approach In pharmaceutical manufacturing, yield reconciliation plays a pivotal role in ensuring that the quantity of material produced aligns with process expectations and quality standards. Deviations in yield reconciliation not only affect batch disposition but may also indicate underlying…

Yield reconciliation GMP guidelines

Root Causes of Batch Reconciliation Failures and How to Fix Them

November 24, 2025November 24, 2025 digi

Root Causes of Batch Reconciliation Failures and How to Fix Them | Pharmaceutical GMP Guide Comprehensive Step-by-Step Guide to Root Causes and Remedies for Batch Reconciliation Failures in Pharmaceutical Manufacturing Batch reconciliation in pharmaceutical manufacturing is a critical quality assurance process ensuring that the quantities of raw materials input correspond precisely with the output and…

Yield & Reconciliation

Typical Line Clearance Deficiencies Found During GMP Audits

November 24, 2025November 24, 2025 digi

Typical Line Clearance Deficiencies Found During GMP Audits Comprehensive Step-by-Step Guide on Line Clearance Procedure Before Batch Start: Identifying & Correcting Common Deficiencies The line clearance procedure before batch start is a critical control point in Good Manufacturing Practice (GMP) manufacturing environments across the pharmaceutical industry. Accurate and thorough line clearance ensures that no cross-contamination,…

Line Clearance

QMS Considerations During Mergers, Acquisitions and Site Transfers

November 22, 2025November 22, 2025 digi

QMS Considerations During Mergers, Acquisitions and Site Transfers Comprehensive Guide to QMS Considerations During Mergers, Acquisitions, and Site Transfers The pharmaceutical industry is extensively regulated, making robust pharmaceutical quality system (QMS) management crucial, especially during significant organizational changes such as mergers, acquisitions, and site transfers. Such transitions often challenge the maintenance of compliance with regulatory…

PQS / QMS / Deviations / CAPA / OOS–OOT

Digital Transformation of the QMS: From Paper SOPs to eQMS Platforms

November 22, 2025November 22, 2025 digi

Digital Transformation of the QMS: From Paper SOPs to eQMS Platforms Digital Transformation of the Pharmaceutical Quality System: Transitioning from Paper SOPs to eQMS Platforms The pharmaceutical industry is continuously evolving, driven by technological advancement and the imperative for regulatory compliance in Good Manufacturing Practice (GMP). Central to quality assurance is the pharmaceutical quality system…

PQS / QMS / Deviations / CAPA / OOS–OOT

Data Integrity and QMS: Ensuring ALCOA+ Across All Quality Processes

November 22, 2025November 22, 2025 digi

Data Integrity and QMS: Ensuring ALCOA+ Across All Quality Processes Ensuring ALCOA+ Data Integrity Across Pharmaceutical Quality Systems and Quality Processes Data integrity is a cornerstone of pharmaceutical quality systems (QMS), essential for safeguarding patient safety and product efficacy. In regulated environments spanning the US, UK, and EU, pharmaceutical quality professionals must uphold the principles…

PQS / QMS / Deviations / CAPA / OOS–OOT

Preparing the PQS for Future Regulatory Trends and Advanced Manufacturing

November 22, 2025November 22, 2025 digi

Preparing the PQS for Future Regulatory Trends and Advanced Manufacturing Comprehensive Step-by-Step Guide to Preparing the Pharmaceutical Quality System for Future Regulatory Trends and Advanced Manufacturing In the evolving landscape of pharmaceutical manufacturing, the pharmaceutical quality system (PQS) stands as the cornerstone of compliance and product excellence. Regulatory expectations across the US, UK, and EU…

PQS / QMS / Deviations / CAPA / OOS–OOT